The physiology and clinical utility of anti-Müllerian hormone in women

Human Reproduction Update - Tập 20 Số 3 - Trang 370-385 - 2014
Didier Dewailly1, Claus Yding Andersen2, Adam Balen3, Frank J. Broekmans4, Nafi Dilaver5, Rénato Fanchin6, Georg Griesinger7, Tom Kelsey8, Antonio La Marca9, Cornelis B. Lambalk10, Helen Mason5, Scott M. Nelson11, Jenny A. Visser12, William H. Wallace13, Richard A. Anderson14
1Department of Endocrine Gynaecology and Reproductive Medicine, Hôpital Jeanne de Flandre, Centre Hospitalier de Lille, Université Lille 2, Lille, France
2Laboratory of Reproductive Biology, Children and Reproduction, University Hospital of Copenhagen, University of Copenhagen, Copenhagen, Denmark
3The Leeds Centre for Reproductive Medicine, Leeds Teaching Hospitals, Leeds LS14 6UH, UK
4Department of Reproductive Medicine and Gynecology, University Medical Centre Utrecht, Utrecht 3584 CX, The Netherlands
5St George's University of London, London SW17 0RE, UK
6Department of Obstetrics Gynecology and Reproductive Medicine, Hospital A. Béclère, University Paris Sud, F-92141 Clamart, France
7Department of Reproductive Medicine and Gynecologic Endocrinology, University Clinic of Schleswig-Holstein, Luebeck, Germany
8School of Computer Science, University of St Andrews, St Andrews KY16 9SX, UK
9Mother-Infant Department, University of Modena and Reggio Emilia, 41100 Modena, Italy
10Division of Reproductive Medicine, Departement of Obstetrics and Gynaecology, VU University Medical Center, Amsterdam, The Netherlands
11Muirhead Chair in Obstetrics & Gynaecology, University of Glasgow, Glasgow G11 6NT, UK
12Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands
13Paediatric Oncology, Royal Hospital for Sick Children, 17 Millerfield Place, Edinburgh EH9 1LF
14MRC Centre for Reproductive Health, Queens Medical Research Centre, University of Edinburgh, Edinburgh, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Acolet, 2005, Confidential Enquiry Into Maternal and Child Health: Pregnancy in Women with Type 1 and Type 2 Diabetes in 2002–03, England, Wales and Northern Ireland

Al-Inany, 2011, Gonadotrophin-releasing hormone antagonists for assisted reproductive technology, Cochrane Database Syst Rev, 10.1002/14651858.CD001750.pub3

Al-Qahtani, 2005, Development of a sensitive enzyme immunoassay for anti-Mullerian hormone and the evaluation of potential clinical applications in males and females, Clin Endocrinol (Oxf), 63, 267, 10.1111/j.1365-2265.2005.02336.x

Almog, 2011, Age-related normograms of serum antimullerian hormone levels in a population of infertile women: a multicenter study, Fertil Steril, 95, 2359, 10.1016/j.fertnstert.2011.02.057

Andersen, 2006, Estradiol and regulation of anti-Mullerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles’ fluid, J Clin Endocrinol Metab, 91, 4064, 10.1210/jc.2006-1066

Andersen, 2008, Increased intrafollicular androgen levels affect human granulosa cell secretion of anti-Mullerian hormone and inhibin-B, Fertil Steril, 89, 1760, 10.1016/j.fertnstert.2007.05.003

Andersen, 2010, Concentrations of AMH and inhibin-B in relation to follicular diameter in normal human small antral follicles, Hum Reprod, 25, 1282, 10.1093/humrep/deq019

Anderson, 2011, Pretreatment serum anti-mullerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer, J Clin Endocrinol Metab, 96, 1336, 10.1210/jc.2010-2582

Anderson, 2012, Measuring anti-Mullerian hormone for the assessment of ovarian reserve: when and for whom is it indicated?, Maturitas, 71, 28, 10.1016/j.maturitas.2011.11.008

Anderson, 2013, Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer, Eur J Cancer, 49, 3404, 10.1016/j.ejca.2013.07.014

Azziz, 2005, Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span, J Clin Endocrinol Metab, 90, 4650, 10.1210/jc.2005-0628

Azziz, 2009, The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report, Fertil Steril, 91, 456, 10.1016/j.fertnstert.2008.06.035

Baarends, 1995, Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth, Endocrinology, 136, 4951, 10.1210/endo.136.11.7588229

Baird, 1993, Inhibin and related peptides in the regulation of reproduction, Oxford Rev Reprod Biol, 15, 191

Baker, 1990, Serum levels of mullerian inhibiting substance in boys from birth to 18 years, as determined by enzyme immunoassay, J Clin Endocrinol Metab, 70, 11, 10.1210/jcem-70-1-11

Balen, 2003, Ultrasound assessment of the polycystic ovary: international consensus definitions, Hum Reprod Update, 9, 505, 10.1093/humupd/dmg044

Bath, 2003, Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound, Hum Reprod, 18, 2368, 10.1093/humrep/deg473

Behringer, 1994, Mullerian-inhibiting substance function during mammalian sexual development, Cell, 79, 415, 10.1016/0092-8674(94)90251-8

Belville, 2004, Mutations of the anti-mullerian hormone gene in patients with persistent mullerian duct syndrome: biosynthesis, secretion, and processing of the abnormal proteins and analysis using a three-dimensional model, Mol Endocrinol, 18, 708, 10.1210/me.2003-0358

Bentzen, 2012, Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception, Reprod Biomed Online, 25, 612, 10.1016/j.rbmo.2012.09.001

Bodri, 2009, Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study, Fertil Steril, 91, 365, 10.1016/j.fertnstert.2007.11.049

Braat, 2010, Maternal death related to IVF in the Netherlands 1984–2008, Hum Reprod, 25, 1782, 10.1093/humrep/deq080

Braem, 2013, Interactions between genetic variants in AMH and AMHR2 may modify age at natural menopause, PloS one, 8, e59819, 10.1371/journal.pone.0059819

Broekmans, 2010, The antral follicle count: practical recommendations for better standardization, Fertil Steril, 94, 1044, 10.1016/j.fertnstert.2009.04.040

Broer, 2009, The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count, Fertil Steril, 91, 705, 10.1016/j.fertnstert.2007.12.013

Broer, 2011, AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis, Hum Reprod Update, 17, 46, 10.1093/humupd/dmq034

Broer, 2011, Anti-Mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women, J Clin Endocrinol Metab, 96, 2532, 10.1210/jc.2010-2776

Broer, 2013, Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach, Hum Reprod Update, 19, 26, 10.1093/humupd/dms041

Brougham, 2012, Anti-Mullerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study, J Clin Endocrinol Metab, 97, 2059, 10.1210/jc.2011-3180

Caanen, 2013, Anti-mullerian hormone serum levels decrease in female to male transsexual women using testosterone as cross-sex therapy, Hum Reprod, 28, 78

Campbell, 2012, The role of anti-Mullerian hormone (AMH) during follicle development in a monovulatory species (sheep), Endocrinology, 153, 4533, 10.1210/en.2012-1158

Carlsen, 2009, Anti-Mullerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome, Hum Reprod, 24, 1732, 10.1093/humrep/dep074

Carlsson, 2006, Anti-Mullerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro, Hum Reprod, 21, 2223, 10.1093/humrep/del165

Carre-Eusebe, 1992, Variants of the anti-Mullerian hormone gene in a compound heterozygote with the persistent Mullerian duct syndrome and his family, Hum Genet, 90, 389, 10.1007/BF00220465

Cate, 1986, Isolation of the bovine and human genes for Mullerian inhibiting substance and expression of the human gene in animal cells, Cell, 45, 685, 10.1016/0092-8674(86)90783-X

Catteau-Jonard, 2007, Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome, J Clin Endocrinol Metab, 92, 4138, 10.1210/jc.2007-0868

Catteau-Jonard, 2008, Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome, J Clin Endocrinol Metab, 93, 4456, 10.1210/jc.2008-1231

Catteau-Jonard, 2012, Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?, Ultrasound Obstet Gynecol, 40, 223, 10.1002/uog.11202

Codner, 2007, Hormonal profile in women with polycystic ovarian syndrome with or without type 1 diabetes mellitus, J Clin Endocrinol Metab, 92, 4742, 10.1210/jc.2007-1252

Crisosto, 2009, Testosterone-induced downregulation of anti-Mullerian hormone expression in granulosa cells from small bovine follicles, Endocrine, 36, 339, 10.1007/s12020-009-9227-6

Dafopoulos, 2010, Smoking and AMH levels in women with normal reproductive history, Arch Gynecol Obstet, 282, 215, 10.1007/s00404-010-1425-1

Das, 2008, Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome, Hum Reprod, 23, 2122, 10.1093/humrep/den185

Decanter, 2010, Anti-Mullerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results, Reprod Biomed Online, 20, 280, 10.1016/j.rbmo.2009.11.010

Dewailly, 2010, Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Mullerian hormone concentrations aggregate with the markers of hyperandrogenism, J Clin Endocrinol Metab, 95, 4399, 10.1210/jc.2010-0334

Dewailly, 2011, Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries, Hum Reprod, 26, 3123, 10.1093/humrep/der297

di Clemente, 1992, A quantitative and interspecific test for biological activity of anti-mullerian hormone: the fetal ovary aromatase assay, Development, 114, 721, 10.1242/dev.114.3.721

Dillon, 2013, Pretreatment antimullerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy, Fertil Steril, 99, 477, 10.1016/j.fertnstert.2012.09.039

Dólleman, 2013, Reproductive and lifestyle determinants of anti-Müllerian hormone in a large population-based study, J Clin Endocrinol Metab, 98, 2106, 10.1210/jc.2012-3995

Durlinger, 1999, Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary, Endocrinology, 140, 5789, 10.1210/endo.140.12.7204

Durlinger, 2001, Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary, Endocrinology, 142, 4891, 10.1210/endo.142.11.8486

Durlinger, 2002, Regulation of ovarian function: the role of anti-Mullerian hormone, Reproduction, 124, 601, 10.1530/rep.0.1240601

Eldar-Geva, 2005, Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism, Hum Reprod, 20, 1814, 10.1093/humrep/deh873

Fanchin, 2003, Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3, Hum Reprod, 18, 323, 10.1093/humrep/deg042

Fanchin, 2005, High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status, Hum Reprod, 20, 923, 10.1093/humrep/deh688

Ferraretti, 2011, ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria, Hum Reprod, 26, 1616, 10.1093/humrep/der092

Fleming, 2012, Reproducibility of AMH, Hum Reprod, 27, 3639, 10.1093/humrep/des343

Fleming, 2012, Interpreting human follicular recruitment and antimullerian hormone concentrations throughout life, Fertil and Steril, 98, 1097, 10.1016/j.fertnstert.2012.07.1114

Fleming, 2013, Stability of AMH measurement in blood and avoidance of proteolytic changes, Reprod Biomed Online, 26, 130, 10.1016/j.rbmo.2012.11.005

Franks, 2008, Polycystic ovary syndrome in adolescents, Int J Obes (Lond), 32, 1035, 10.1038/ijo.2008.61

Freeman, 2007, Association of anti-mullerian hormone levels with obesity in late reproductive-age women, Fertil Steril, 87, 101, 10.1016/j.fertnstert.2006.05.074

Freour, 2007, Measurement of serum anti-Mullerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART), Clin Chim Acta; Int J Clin Chem, 375, 162, 10.1016/j.cca.2006.06.013

Freour, 2012, Ovarian reserve and in vitro fertilization cycles outcome according to women smoking status and stimulation regimen, Arch Gynecol Obstet, 285, 1177, 10.1007/s00404-011-2172-7

Genro, 2011, Serum anti-Mullerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation, Hum Reprod, 26, 671, 10.1093/humrep/deq361

Gigli, 2005, Evidence for a role for anti-Mullerian hormone in the suppression of follicle activation in mouse ovaries and bovine ovarian cortex grafted beneath the chick chorioallantoic membrane, Mol Reprod Dev, 71, 480, 10.1002/mrd.20338

Gilling-Smith, 1994, Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries, J Clin Endocrinol Metab, 79, 1158

Gougeon, 1998, Ovarian follicular growth in humans: ovarian ageing and population of growing follicles, Maturitas, 30, 137, 10.1016/S0378-5122(98)00069-3

Gracia, 2012, Impact of cancer therapies on ovarian reserve, Fertil Steril, 97, 134, 10.1016/j.fertnstert.2011.10.040

Grondahl, 2011, Anti-Mullerian hormone remains highly expressed in human cumulus cells during the final stages of folliculogenesis, Reprod Biomed Online, 22, 389, 10.1016/j.rbmo.2010.12.005

Grossman, 2008, Mullerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture, Fertil Steril, 89, 1364, 10.1016/j.fertnstert.2007.03.066

Grynberg, 2012, Differential regulation of ovarian anti-müllerian hormone (AMH) by estradiol through α- and β-estrogen receptors, J Clin Endocrinol Metab, 97, E1649, 10.1210/jc.2011-3133

Hadlow, 2013, Variation in antimullerian hormone concentration during the menstrual cycle may change the clinical classification of the ovarian response, Fertil Steril, 99, 1791, 10.1016/j.fertnstert.2013.01.132

Hagen, 2012, Low concentration of circulating anti-Müllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study, Fertil Steril, 98, 1602, 10.1016/j.fertnstert.2012.08.008

Halawaty, 2010, Effect of obesity on parameters of ovarian reserve in premenopausal women, J Obstet Gynaecol Can, 32, 687, 10.1016/S1701-2163(16)34573-X

Hamre, 2012, Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study, Pediatric Blood Cancer, 59, 271, 10.1002/pbc.23363

Hansen, 2011, Correlation of ovarian reserve tests with histologically determined primordial follicle number, Fertil Steril, 95, 170, 10.1016/j.fertnstert.2010.04.006

Hart, 2010, Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS), Fertil Steril, 94, 1118, 10.1016/j.fertnstert.2009.11.002

Hehenkamp, 2006, Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation, J Clin Endocrinol Metab, 91, 4057, 10.1210/jc.2006-0331

Hendriks, 2008, Expected poor ovarian response in predicting cumulative pregnancy rates: a powerful tool, Reprod Biomed Online, 17, 727, 10.1016/S1472-6483(10)60323-9

Hudson, 1990, An immunoassay to detect human mullerian inhibiting substance in males and females during normal development, J Clin Endocrinol Metab, 70, 16, 10.1210/jcem-70-1-16

Hughesdon, 1982, Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called ‘hyperthecosis, Obstet Gynecol Surv, 37, 59, 10.1097/00006254-198202000-00001

Hutson, 1981, The ontogeny of Mullerian inhibiting substance in the gonads of the chicken, J Pediatr Surg, 16, 822, 10.1016/S0022-3468(81)80827-5

Iliodromiti, 2013, Can anti-mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data, J Clin Endocrinol Metab, 98, 3332, 10.1210/jc.2013-1393

Jeppesen, 2013, Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection, Mol Hum Reprod, 19, 519, 10.1093/molehr/gat024

Josso, 1990, An enzyme linked immunoassay for anti-mullerian hormone: a new tool for the evaluation of testicular function in infants and children, J Clin Endocrinol Metab, 70, 23, 10.1210/jcem-70-1-23

Josso, 1993, Anti-mullerian hormone: the Jost factor, Recent Prog Horm Res, 48, 1

Jost, 1947, The age factor in the castration of male rabbit fetuses, Proc Soc Exp Biol Med, 66, 302, 10.3181/00379727-66-16071

Kallio, 2013, Antimullerian hormone levels decrease in women using combined contraception independently of administration route, Fertil Steril, 99, 1305, 10.1016/j.fertnstert.2012.11.034

Kelsey, 2011, A validated model of serum anti-Müllerian hormone from conception to menopause, PloS one, 6, e22024, 10.1371/journal.pone.0022024

Kelsey, 2012, Data-driven assessment of the human ovarian reserve, Mol Hum Reprod, 18, 79, 10.1093/molehr/gar059

Kevenaar, 2006, Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice, Endocrinology, 147, 3228, 10.1210/en.2005-1588

Kevenaar, 2007, Anti-Mullerian hormone and anti-Mullerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women, Hum Reprod, 22, 1547, 10.1093/humrep/dem036

Kevenaar, 2008, A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients, J Clin Endocrinol Metab, 93, 1310, 10.1210/jc.2007-2205

Köninger, 2013, Anti-Mullerian-hormone levels during pregnancy and postpartum, Reprod Biol Endocrinol, 11, 60, 10.1186/1477-7827-11-60

Kosova, 2013, Genetics of the polycystic ovary syndrome, Mol Cell Endocrinol, 373, 29, 10.1016/j.mce.2012.10.009

Kumar, 2010, Development of a second generation anti-Mullerian hormone (AMH) ELISA, J Immunol Methods, 362, 51, 10.1016/j.jim.2010.08.011

La Marca, 2007, The Anti-Mullerian hormone and ovarian cancer, Hum Reprod Update, 13, 265, 10.1093/humupd/dml060

La Marca, 2006, Serum anti-Mullerian hormone throughout the human menstrual cycle, Hum Reprod, 21, 3103, 10.1093/humrep/del291

La Marca, 2010, Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART), Hum Reprod Update, 16, 113, 10.1093/humupd/dmp036

La Marca, 2011, Age-specific nomogram for the decline in antral follicle count throughout the reproductive period, Fertil Steril, 95, 684, 10.1016/j.fertnstert.2010.07.1069

La Marca, 2011, Anti-Mullerian hormone-based prediction model for a live birth in assisted reproduction, Reprod Biomed Online, 22, 341, 10.1016/j.rbmo.2010.11.005

La Marca, 2012, Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles, BJOG, 119, 1171, 10.1111/j.1471-0528.2012.03412.x

La Marca, 2012, Normal serum anti-Mullerian hormone levels in the general female population and the relationship with reproductive history, Eur J Obstet Gynecol Reprod Biol, 163, 180, 10.1016/j.ejogrb.2012.04.013

Laven, 2004, Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age, J Clin Endocrinol Metab, 89, 318, 10.1210/jc.2003-030932

Lawlor, 2012, Effect of age on decisions about the numbers of embryos to transfer in assisted conception: a prospective study, Lancet, 379, 521, 10.1016/S0140-6736(11)61267-1

Lee, 1993, Mullerian inhibiting substance: a gonadal hormone with multiple functions, Endocrine Reviews, 14, 152

Lee, 2011, Antimullerian hormone as a predictor of controlled ovarian hyperstimulation outcome: comparison of two commercial immunoassay kits, Fertil Steril, 95, 2602, 10.1016/j.fertnstert.2011.01.126

Li, 2011, Evaluation of serum antimullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrhea, Fertil Steril, 96, 774, 10.1016/j.fertnstert.2011.06.016

Li, 2012, Correlation between three assay systems for anti-Mullerian hormone (AMH) determination, J Assist Reprod Genet, 29, 1443, 10.1007/s10815-012-9880-1

Lie Fong, 2009, Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone, Hum Reprod, 24, 982, 10.1093/humrep/den487

Lie Fong, 2011, Serum anti-Mullerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome, Fertil Steril, 96, 459, 10.1016/j.fertnstert.2011.05.084

Long, 2000, Detection of minimal levels of serum anti-Mullerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay, J Clin Endocrinol Metab, 85, 540

Lujan, 2013, Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume, Hum Reprod, 28, 1361, 10.1093/humrep/det062

Maciel, 2004, Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome, J Clin Endocrinol Metab, 89, 5321, 10.1210/jc.2004-0643

Mutlu, 2013, Antral follicle count determines poor ovarian response better than anti-Mullerian hormone but age is the only predictor for live birth in in vitro fertilization cycles, J Assist Reprod Genet, 30, 657, 10.1007/s10815-013-9975-3

Nachtigal, 1996, Bioactivation of Mullerian inhibiting substance during gonadal development by a kex2/subtilisin-like endoprotease, Proc Natl Acad Sci USA, 93, 7711, 10.1073/pnas.93.15.7711

Nardo, 2007, Anti-Mullerian hormone levels and antral follicle count in women enrolled in in vitro fertilization cycles: relationship to lifestyle factors, chronological age and reproductive history, Gynecol Endocrinol, 23, 486, 10.1080/09513590701532815

Nelson, 2011, Predicting live birth, preterm delivery, and low birth weight in infants born from in vitro fertilisation: a prospective study of 144,018 treatment cycles, PLoS Med, 8, e1000386, 10.1371/journal.pmed.1000386

Nelson, 2007, Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles—implications for individualization of therapy, Hum Reprod, 22, 2414, 10.1093/humrep/dem204

Nelson, 2009, Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception, Hum Reprod, 24, 867, 10.1093/humrep/den480

Nelson, 2010, Longitudinal assessment of antimullerian hormone during pregnancy-relationship with maternal adiposity, insulin, and adiponectin, Fertil Steril, 93, 1356, 10.1016/j.fertnstert.2009.07.1676

Nelson, 2011, External validation of nomogram for the decline in serum anti-Mullerian hormone in women: a population study of 15,834 infertility patients, Reprod Biomed Online, 23, 204, 10.1016/j.rbmo.2011.05.006

Nelson, 2011, Nomogram for the decline in serum antimullerian hormone: a population study of 9,601 infertility patients, Fertil Steril, 95, 736, 10.1016/j.fertnstert.2010.08.022

Nielsen, 2011, In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA, Mol Hum Reprod, 17, 63, 10.1093/molehr/gaq073

Nilsson, 2007, Actions of anti-Mullerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition, Reproduction, 134, 209, 10.1530/REP-07-0119

Overbeek, 2012, Intra-cycle fluctuations of anti-Mullerian hormone in normal women with a regular cycle: a re-analysis, Reprod Biomed Online, 24, 664, 10.1016/j.rbmo.2012.02.023

Panidis, 2011, Serum Anti-Mullerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum Follicle Stimulating Hormone (FSH) levels, Med Hypotheses, 77, 649, 10.1016/j.mehy.2011.07.005

Park, 2010, Serum anti-Mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism, J Clin Endocr Metab, 95, 1786, 10.1210/jc.2009-2106

Partridge, 2010, Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer, Fertil Steril, 94, 638, 10.1016/j.fertnstert.2009.03.045

Pellatt, 2007, Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries, J Clin Endocrinol Metab, 92, 240, 10.1210/jc.2006-1582

Pellatt, 2010, Anti-Mullerian hormone and polycystic ovary syndrome: a mountain too high?, Reproduction, 139, 825, 10.1530/REP-09-0415

Pellatt, 2011, Anti-Mullerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells, Fertil Steril, 96, 1246, 10.1016/j.fertnstert.2011.08.015

Pepinsky, 1988, Proteolytic processing of mullerian inhibiting substance produces a transforming growth factor-beta-like fragment, J Biol Chem, 263, 18961, 10.1016/S0021-9258(18)37375-7

Picard, 1984, Purification of testicular anti-Müllerian hormone allowing direct visualization of the pure glycoprotein and determination of yield and purification factor, Mol Cell Endocrinol, 34, 23, 10.1016/0303-7207(84)90155-2

Pierre, 2013, Loss of LH-induced down-regulation of anti-Mullerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome, Hum Reprod, 28, 762, 10.1093/humrep/des460

Pigny, 2003, Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest, J Clin Endocrinol Metab, 88, 5957, 10.1210/jc.2003-030727

Piouka, 2009, Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels, Am J Physiol Endocrinol Metab, 296, E238, 10.1152/ajpendo.90684.2008

Plante, 2010, The impact of smoking on antimullerian hormone levels in women aged 38 to 50 years, Menopause, 17, 571, 10.1097/gme.0b013e3181c7deba

Raffi, 2012, The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis, J Clin Endocrinol Metab, 97, 3146, 10.1210/jc.2012-1558

Rajpert-De Meyts, 1999, Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells, J Clin Endocrinol Metab, 84, 3836

Rey, 2000, Anti-Müllerian hormone is a specific marker of Sertoli- and granulosa-cell origin in gonadal tumors, Hum Pathol, 31, 1202, 10.1053/hupa.2000.18498

Robin, 2012, Polycystic Ovary-Like Abnormalities (PCO-L) in women with functional hypothalamic amenorrhea, J Clin Endocrinol Metab, 97, 4236, 10.1210/jc.2012-1836

Rosendahl, 2008, Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study, Hum Reprod, 23, 2475, 10.1093/humrep/den248

Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group, 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS), Hum Reprod, 19, 41, 10.1093/humrep/deh098

Rustamov, 2012, Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability, Hum Reprod, 27, 3085, 10.1093/humrep/des260

Salmon, 2004, Oocyte regulation of anti-Mullerian hormone expression in granulosa cells during ovarian follicle development in mice, Dev Biol, 266, 201, 10.1016/j.ydbio.2003.10.009

Schipper, 2012, Limitations and pitfalls of antimullerian hormone measurements, Fertil Steril, 98, 823, 10.1016/j.fertnstert.2012.07.1105

Schmidt, 2005, Anti-Mullerian hormone initiates growth of human primordial follicles in vitro, Mol Cell Endocrinol, 234, 87, 10.1016/j.mce.2004.12.010

Schuh-Huerta, 2012, Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women, Hum Reprod, 27, 594, 10.1093/humrep/der391

Seifer, 2009, Variations in serum mullerian inhibiting substance between white, black, and Hispanic women, Fertil Steril, 92, 1674, 10.1016/j.fertnstert.2008.08.110

Skalba, 2011, Is the plasma anti-Mullerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?, Eur J Obstet Gynecol Reprod Biol, 158, 254, 10.1016/j.ejogrb.2011.06.006

Somigliana, 2012, Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimullerian hormone level modifications, Fertil Steril, 98, 1531, 10.1016/j.fertnstert.2012.08.009

Sowers, 2010, Anti-Mullerian hormone and inhibin B variability during normal menstrual cycles, Fertil Steril, 94, 1482, 10.1016/j.fertnstert.2009.07.1674

Steiner, 2010, Antimullerian hormone and obesity: insights in oral contraceptive users, Contraception, 81, 245, 10.1016/j.contraception.2009.10.004

Streuli, 2009, Clinical uses of anti-Mullerian hormone assays: pitfalls and promises, Fertil Steril, 91, 226, 10.1016/j.fertnstert.2007.10.067

Streuli, 2012, In women with endometriosis anti-Mullerian hormone levels are decreased only in those with previous endometrioma surgery, Hum Reprod, 27, 3294, 10.1093/humrep/des274

Stubbs, 2005, Anti-mullerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries, J Clin Endocrinol Metab, 90, 5536, 10.1210/jc.2005-0907

Su, 2013, Impact of breast cancer on anti-mullerian hormone levels in young women, Breast Cancer Res Treat, 137, 571, 10.1007/s10549-012-2361-5

Tehrani, 2009, A single test of antimullerian hormone in late reproductive-aged women is a good predictor of menopause, Menopause, 16, 797, 10.1097/GME.0b013e318193e95d

Tehrani, 2013, Modeling age at menopause using serum concentration of anti-mullerian hormone, J Clin Endocrinol Metab, 98, 729, 10.1210/jc.2012-3176

Tsepelidis, 2007, Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women, Hum Reprod, 22, 1837, 10.1093/humrep/dem101

van Beek, 2007, Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood, J Clin Endocrinol Metab, 92, 3869, 10.1210/jc.2006-2374

van den Berg, 2010, Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases, Hum Reprod, 25, 1520, 10.1093/humrep/deq071

van Disseldorp, 2010, Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts, Hum Reprod, 25, 221, 10.1093/humrep/dep366

van Houten, 2010, Anti-Müllerian hormone (AMH): regulator and marker of ovarian function, Ann Endocrinol (Paris), 71, 191, 10.1016/j.ando.2010.02.016

Veiga-Lopez, 2011, Developmental programming: impact of excess prenatal testosterone on intrauterine fetal endocrine milieu and growth in sheep, Biol Reprod, 84, 87, 10.1095/biolreprod.110.086686

Vigier, 1989, Anti-Mullerian hormone produces endocrine sex reversal of fetal ovaries, Proc Natl Acad Sci USA, 86, 3684, 10.1073/pnas.86.10.3684

Villarroel, 2011, Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone, Hum Reprod, 26, 2861, 10.1093/humrep/der223

Visser, 2005, Anti-Mullerian hormone and folliculogenesis, Mol Cell Endocrinol, 234, 81, 10.1016/j.mce.2004.09.008

Visser, 2006, Anti-Mullerian hormone: a new marker for ovarian function, Reproduction, 131, 1, 10.1530/rep.1.00529

Visser, 2007, Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-Mullerian hormone null mice, Endocrinology, 148, 2301, 10.1210/en.2006-1265

Voorhuis, 2010, Human studies on genetics of the age at natural menopause: a systematic review, Hum Reprod Update, 16, 364, 10.1093/humupd/dmp055

Wallace, 2010, Human ovarian reserve from conception to the menopause, PLoS One, 5, e8772, 10.1371/journal.pone.0008772

Wallace, 2011, A multicentre evaluation of the new Beckman Coulter anti-Mullerian hormone immunoassay (AMH Gen II), Ann Clin Biochem, 48, 370, 10.1258/acb.2011.010172

Waylen, 2010, Effect of cigarette smoking upon reproductive hormones in women of reproductive age: a retrospective analysis, Reprod Biomed Online, 20, 861, 10.1016/j.rbmo.2010.02.021

Webber, 2003, Formation and early development of follicles in the polycystic ovary, Lancet, 362, 1017, 10.1016/S0140-6736(03)14410-8

Weenen, 2004, Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment, Mol Hum Reprod, 10, 77, 10.1093/molehr/gah015

Wilson, 1993, Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily, Mol Endocrinol, 7, 247

Yates, 2011, Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF, Hum Reprod, 26, 2353, 10.1093/humrep/der182